iRhythm Holdings, Inc. (IRTC)

Market Cap	3.91B +17.6%
Revenue (ttm)	747.14M +26.2%
Net Income	-44.55M
EPS	-1.39
Shares Out	32.32M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	35,505
Open	119.91
Previous Close	118.88
Day's Range	118.00 - 121.76
52-Week Range	97.16 - 212.00
Beta	1.18
Analysts	Strong Buy
Price Target	197.92 (+63.42%)
Earnings Date	Apr 30, 2026

About IRTC

iRhythm Holdings, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology that provides ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. The company offers Zio ambulatory cardiac monitoring services, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. It also provides Zio Monitor System, a prescription-only remote electrocardiogram (ECG) monitoring system consisting a patch ECG monitor that ...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: Oct 20, 2016
• Employees: 2,400
• Stock Exchange: NASDAQ
• Ticker Symbol: IRTC
• Website: https://www.irhythmtech.com

Financial Performance

In 2025, iRhythm Holdings's revenue was $747.14 million, an increase of 26.24% compared to the previous year's $591.84 million. Losses were -$44.55 million, -60.67% less than in 2024.

Analyst Summary

According to 13 analysts, the average rating for IRTC stock is "Strong Buy." The 12-month stock price target is $197.92, which is an increase of 63.42% from the latest price.

Price Target

$197.92

(63.42% upside)

Analyst Consensus: Strong Buy